Noticias y Actividades de Gain Therapeutics
Ejecutivos
Ver el organigrama con sus 15 ejecutivos principales
Biografías más buscadas en Gain Therapeutics
- Gene Mack, Chief Executive Officer and President
- Hans Peter Hasler, Independent Member
- Jeffrey Riley, Independent Member
Recientes movimientos de ejecutivos en Gain Therapeutics
- Gene Mack que ha sido Chief Financial Officer and Interim Chief Executive Officer, pasa a ser Chief Executive Officer and President (noticia publicada el 7 de enero de 2025).
- Gianluca Fuggetta que ha sido Vice President, Finance, ha ascendido a Senior Vice President Finance (noticia publicada el 7 de enero de 2025).
Crear su alerta
para seguir los movimientos de los ejecutivos en Gain Therapeutics.
Biotecnología
Gain Therapeutics tiene 2.347 competidores entre los que se incluyen Eurofins (Luxemburgo), Lonza (Suiza) y Johnson & Johnson Innovative Medicine DIA (Estados Unidos).
Popular M&A news in Biotecnología
- Attovia Therapeutics acaba de anunciar una recaudación de fondos de 90 millones de dólares. (publicado el 21 de abril de 2025).
- Transcarent and Accolade have merged (publicado el 9 de abril de 2025)..
- Kashiv BioSciences acaba de anunciar una recaudación de fondos de 150 millones de dólares. (publicado el 7 de abril de 2025).
Otros contactos sugeridos en el sector Biotecnología
Noticias
Últimos comunicados de prensa de Gain Therapeutics
- Gain Therapeutics Presents Additional Preclinical Data and Design of Phase 1b Clinical Study of GT-02287 at AD/PD 2025 and Provides Enrollment Update
- Gain Therapeutics Announces Poster Presentation at AD/PD 2025
- Gain Therapeutics Reports Financial Results for the Fourth Quarter and Year End 2024 and Provides Corporate Update
- ROTH Fireside Chat with President & CEO Gene Mack
- Gain Therapeutics Doses First Participant in Phase 1b Clinical Trial of GT-02287 in Parkinson’s Disease
- Gain Therapeutics CEO Gene Mack Issues Letter To Shareholders and Provides Operational Update
- Gain Therapeutics To Participate in Upcoming Investor Conferences
- Gain Therapeutics Announces Formation of Clinical Advisory Board to Support Continued Advancement of Lead Drug Candidate GT-02287
- Gain Therapeutics Appoints Gene Mack as Chief Executive Officer and Director
- GT-02287 may slow Parkinson’s progression, new early data suggest
- View more press releases Close
Redes sociales sobre Gain Therapeutics
- Gain Therapeutics en Wikipedia, Google News y Yahoo Finance
- Gain Therapeutics en LinkedIn, Twitter y YouTube
